These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35158297)

  • 1. Rv1258c acts as a drug efflux pump and growth controlling factor in Mycobacterium tuberculosis.
    Jia H; Chu H; Dai G; Cao T; Sun Z
    Tuberculosis (Edinb); 2022 Mar; 133():102172. PubMed ID: 35158297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
    Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
    Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5' untranslated region of whiB7.
    Reeves AZ; Campbell PJ; Sultana R; Malik S; Murray M; Plikaytis BB; Shinnick TM; Posey JE
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1857-65. PubMed ID: 23380727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.
    Sharma S; Kumar M; Sharma S; Nargotra A; Koul S; Khan IA
    J Antimicrob Chemother; 2010 Aug; 65(8):1694-701. PubMed ID: 20525733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
    Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
    BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c.
    Cloete R; Kapp E; Joubert J; Christoffels A; Malan SF
    PLoS One; 2018; 13(11):e0207605. PubMed ID: 30475855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.
    Kardan-Yamchi J; Kazemian H; Haeili M; Harati AA; Amini S; Feizabadi MM
    J Glob Antimicrob Resist; 2019 Jun; 17():201-208. PubMed ID: 30654147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in
    Liu J; Shi W; Zhang S; Hao X; Maslov DA; Shur KV; Bekker OB; Danilenko VN; Zhang Y
    Front Microbiol; 2019; 10():216. PubMed ID: 30837962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TB-EFI, a novel 18-Plex microbead-based method for prediction of second-line drugs and ethambutol resistance in Mycobacterium tuberculosis complex.
    Klotoe BJ; Molina-Moya B; Gomes HM; Gomgnimbou MK; Oliveira Suzarte L; Féres Saad MH; Ali S; Dominguez J; Pimkina E; Zholdybayeva E; Sola C; Refrégier G
    J Microbiol Methods; 2018 Sep; 152():10-17. PubMed ID: 29913189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis.
    Malinga L; Brand J; Olorunju S; Stoltz A; van der Walt M
    Diagn Microbiol Infect Dis; 2016 Aug; 85(4):433-7. PubMed ID: 27298046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.
    Rodrigues L; Machado D; Couto I; Amaral L; Viveiros M
    Infect Genet Evol; 2012 Jun; 12(4):695-700. PubMed ID: 21871582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Campbell PJ; Morlock GP; Sikes RD; Dalton TL; Metchock B; Starks AM; Hooks DP; Cowan LS; Plikaytis BB; Posey JE
    Antimicrob Agents Chemother; 2011 May; 55(5):2032-41. PubMed ID: 21300839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
    Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    J Clin Microbiol; 2009 Jun; 47(6):1767-72. PubMed ID: 19386845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
    Dymova MA; Cherednichenko AG; Alkhovik OI; Khrapov EA; Petrenko TI; Filipenko ML
    BMC Infect Dis; 2014 Sep; 14():478. PubMed ID: 25186134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
    Mao X; Ke Z; Shi X; Liu S; Tang B; Wang J; Huang H
    Ann Clin Lab Sci; 2015; 45(5):533-44. PubMed ID: 26586705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.